LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Search

Cencora Inc

Gesloten

SectorGezondheidszorg

366.53 1

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

362.34

Max

368.19

Belangrijke statistieken

By Trading Economics

Inkomsten

906M

566M

Verkoop

2.2B

86B

K/W

Sectorgemiddelde

43.836

108.767

EPS

2.87

Dividendrendement

0.62

Winstmarge

0.659

Werknemers

47,000

EBITDA

858M

1B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+15.28% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.62%

2.21%

Volgende Winsten

6 mei 2026

Volgende dividenddatum

2 mrt 2026

Volgende Ex Dividend datum

15 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

482M

71B

Vorige openingsprijs

365.53

Vorige sluitingsprijs

366.53

Nieuwssentiment

By Acuity

34%

66%

103 / 352 Rangschikking in Healthcare

Cencora Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 feb 2026, 22:04 UTC

Winsten

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26 feb 2026, 23:55 UTC

Marktinformatie

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26 feb 2026, 23:40 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26 feb 2026, 23:37 UTC

Marktinformatie

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26 feb 2026, 23:32 UTC

Winsten

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26 feb 2026, 23:19 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 feb 2026, 23:18 UTC

Acquisities, Fusies, Overnames

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 feb 2026, 23:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

26 feb 2026, 23:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26 feb 2026, 23:01 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb 2026, 23:00 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 feb 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 feb 2026, 22:43 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

26 feb 2026, 22:43 UTC

Marktinformatie

RBA Hike In March Is Being Underpriced -- Market Talk

26 feb 2026, 22:33 UTC

Acquisities, Fusies, Overnames

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 feb 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 feb 2026, 22:13 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26 feb 2026, 21:59 UTC

Winsten

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26 feb 2026, 21:58 UTC

Acquisities, Fusies, Overnames

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

26 feb 2026, 21:49 UTC

Winsten

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26 feb 2026, 21:45 UTC

Winsten

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26 feb 2026, 21:44 UTC

Winsten

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26 feb 2026, 21:44 UTC

Winsten

Coles Expects Market to Remain Highly Competitive

26 feb 2026, 21:44 UTC

Winsten

Coles Says Supermarket Customers Remain Value Oriented

26 feb 2026, 21:43 UTC

Winsten

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26 feb 2026, 21:43 UTC

Winsten

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26 feb 2026, 21:42 UTC

Acquisities, Fusies, Overnames

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26 feb 2026, 21:41 UTC

Winsten
Acquisities, Fusies, Overnames

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Peer Vergelijking

Prijswijziging

Cencora Inc Prognose

Koersdoel

By TipRanks

15.28% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 418.5 USD  15.28%

Hoogste 440 USD

Laagste 400 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cencora Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Sentiment

By Acuity

103 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat